Table II.
Total | CTC status | ||||
---|---|---|---|---|---|
Stage | Total (%) | Alive | Deceased | Detected | Not detected |
1 | 15 (45.4%) | 9 (60%) | 6 (40%) | 13 (87%) | 2 (13%) |
2 | 11 (33.3%) | 8 (73%) | 3 (27%) | 8 (73%) | 3 (27%) |
3 | 6 (18.1%) | 3 (50%) | 3 (50%) | 5 (83%) | 1 (17%) |
4 | 1 (3.3%) | 0 (0%) | 1 (100%) | 0 (0%) | 1 (100%) |
Total | 33 | 20 (61%) | 13 (39%) | 26 (79%) | 7 (21%) |
There was no direct correlation between the stage and detection of CTCs. A Pearson's analysis between proportion of patients with positive CTCs status and lung cancer stage demonstrated a negative correlation, Pearson's r=-0.80, P=0.20. CTC, circulating tumour cells.